BR9507634A - Compostos ou suas composições e uso dos mesmos - Google Patents

Compostos ou suas composições e uso dos mesmos

Info

Publication number: BR9507634A
Authority: BR; Brazil
Prior art keywords: pct; derivatives; compositions; compounds; oxy
Prior art date: 1994-05-10

Application number

BR9507634A

Other languages

English (en)

Inventor

Soldato Piero Del

Francesco Sannicolo

Original Assignee

Nicox Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-05-10

Filing date

1995-04-04

Publication date

1997-09-23

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26331127&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9507634(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1994-05-10 Priority claimed from ITMI940916A external-priority patent/IT1269735B/it

1994-08-09 Priority claimed from ITMI941731A external-priority patent/IT1274609B/it

1995-04-04 Application filed by Nicox Sa filed Critical Nicox Sa

1997-09-23 Publication of BR9507634A publication Critical patent/BR9507634A/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C203/00—Esters of nitric or nitrous acid
- C07C203/02—Esters of nitric acid
- C07C203/04—Esters of nitric acid having nitrate groups bound to acyclic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/26—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
- C07D209/28—1-(4-Chlorobenzoyl)-2-methyl-indolyl-3-acetic acid, substituted in position 5 by an oxygen or nitrogen atom; Esters thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pain & Pain Management (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Biomedical Technology (AREA)
Hematology (AREA)
Diabetes (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Rheumatology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Pyrane Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Indole Compounds (AREA)
Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Pyridine Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Pyrrole Compounds (AREA)

BR9507634A 1994-05-10 1995-04-04 Compostos ou suas composições e uso dos mesmos BR9507634A (pt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
ITMI940916A IT1269735B (it)	1994-05-10	1994-05-10	Prodotti provvisti di un gruppo nitroestere terminale dotati di attivita' anti-infiammatoria e/o analgesica
ITMI941731A IT1274609B (it)	1994-08-09	1994-08-09	Nitro-inibitori aventi attivita' anti-infiammatoria
PCT/EP1995/001233 WO1995030641A1 (en)	1994-05-10	1995-04-04	Nitro compounds and their compositions having anti-inflammatory, analgesic and anti-thrombotic acitivities

Publications (1)

Publication Number	Publication Date
BR9507634A true BR9507634A (pt)	1997-09-23

Family

ID=26331127

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BR9507634A BR9507634A (pt)	1994-05-10	1995-04-04	Compostos ou suas composições e uso dos mesmos

Country Status (17)

Country	Link
US (1)	US5861426A (pt)
EP (1)	EP0759899B1 (pt)
JP (1)	JP4043046B2 (pt)
KR (1)	KR100387359B1 (pt)
AT (1)	ATE184589T1 (pt)
AU (1)	AU702662B2 (pt)
BR (1)	BR9507634A (pt)
CA (1)	CA2190087C (pt)
DE (1)	DE69512232T2 (pt)
DK (1)	DK0759899T3 (pt)
ES (1)	ES2139199T3 (pt)
GR (1)	GR3032078T3 (pt)
HU (1)	HU227280B1 (pt)
IL (1)	IL113255A0 (pt)
RU (1)	RU2145595C1 (pt)
SI (1)	SI0759899T1 (pt)
WO (1)	WO1995030641A1 (pt)

Families Citing this family (104)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6043232A (en) *	1997-07-23	2000-03-28	Nitromed, Inc.	Nitroso esters of beta-oxo-amides and aryl propionic acid derivatives of non-steroidal antiinflammatory drugs
US5703073A (en)	1995-04-19	1997-12-30	Nitromed, Inc.	Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
DE19515970A1 (de) *	1995-05-02	1996-11-07	Bayer Ag	Acetylsalicylsäurenitrate
IT1276071B1 (it) *	1995-10-31	1997-10-24	Nicox Ltd	Compositi ad attivita' anti-infiammatoria
SE9600070D0 (sv)	1996-01-08	1996-01-08	Astra Ab	New oral pharmaceutical dosage forms
IT1282686B1 (it)	1996-02-26	1998-03-31	Nicox Sa	Composti in grado di ridurre la tossicita' da farmaci
US20050137191A1 (en) *	1996-06-04	2005-06-23	Thatcher Gregory R.	Nitrate esters and their use for mitigating cellular damage
US6310052B1 (en)	1996-06-04	2001-10-30	Queen's University At Kingston	Nitrate esters and their use for neurological conditions
US7115661B1 (en) *	1999-12-29	2006-10-03	Queen's University At Kingston	Methods and compositions for mitigating pain
US20040082652A1 (en) *	1996-09-04	2004-04-29	Nicox S.A.	Nitric ester derivatives and their use in treating gastrointestinal tumors
IT1288123B1 (it) *	1996-09-04	1998-09-10	Nicox Sa	Uso di nitroderivati per l'incontinenza urinaria
IT1285770B1 (it)	1996-10-04	1998-06-18	Nicox Sa	Composti corticoidei
IT1295694B1 (it) *	1996-11-14	1999-05-27	Nicox Sa	Nitrossi derivati per la preparazione di medicamenti ad attivita antitrombinica
FR2757159B1 (fr) *	1996-12-12	1999-12-17	Hoechst Marion Roussel Inc	Nouveaux derives nitres analgesiques, anti-inflammatoires et anti-thrombotiques, leur procede de preparation, leur application comme medicaments
IL120531A (en) *	1997-03-26	2006-12-31	Yissum Res Dev Co	Nitric oxide donors and pharmaceutical compositions containing them
IT1292377B1 (it)	1997-06-19	1999-02-08	Nicox Sa	Composizioni farmaceutiche a base di prostaglandine
IT1292426B1 (it)	1997-06-27	1999-02-08	Nicox Sa	Sali nitrati di ace-inibitori
GB9801398D0 (en)	1998-01-22	1998-03-18	Anggard Erik E	Chemical compounds
IT1301759B1 (it)	1998-06-19	2000-07-07	Nicox Sa	Sali nitrati di farmaci antiipertensivi
IT1303671B1 (it) *	1998-07-28	2001-02-23	Nicox Sa	Sali dell'acido nitrico con farmaci attivi nel trattamento dipatologie del sistema respiratorio
IT1303672B1 (it) *	1998-07-28	2001-02-23	Nicox Sa	Sali nitrati di farmaci attivi nei disordini ossei
EP0984012A3 (en) *	1998-08-31	2001-01-10	Pfizer Products Inc.	Nitric oxide releasing oxindole prodrugs with analgesic and anti-inflammatory properties
CA2348741C (en) *	1998-10-30	2010-04-20	Nitromed Inc.	Nitrosasted and nitrosylated nonsteroidal antiinflammatory compounds, comositions and methods of use
IT1308633B1 (it) *	1999-03-02	2002-01-09	Nicox Sa	Nitrossiderivati.
IT1311923B1 (it)	1999-04-13	2002-03-20	Nicox Sa	Composti farmaceutici.
IT1311924B1 (it) *	1999-04-13	2002-03-20	Nicox Sa	Composti farmaceutici.
TWI243672B (en)	1999-06-01	2005-11-21	Astrazeneca Ab	New use of compounds as antibacterial agents
US7169889B1 (en)	1999-06-19	2007-01-30	Biocon Limited	Insulin prodrugs hydrolyzable in vivo to yield peglylated insulin
US6309633B1 (en)	1999-06-19	2001-10-30	Nobex Corporation	Amphiphilic drug-oligomer conjugates with hydroyzable lipophile components and methods for making and using the same
IT1312115B1 (it) *	1999-06-24	2002-04-04	Nicox Sa	Composti amorfi e relative composizioni farmaceutiche
IT1313596B1 (it) *	1999-08-04	2002-09-09	Nicox Sa	Processo per la preparazione di nitrossialchil esteri del naproxene
IT1314184B1 (it) *	1999-08-12	2002-12-06	Nicox Sa	Composizioni farmaceutiche per la terapia di condizioni di stressossidativo
TWI262791B (en)	1999-10-27	2006-10-01	Nobex Corp	6-methoxy-2-naphthylacetic acid prodrugs
US6552078B2 (en)	1999-10-27	2003-04-22	Nobex Corp	6-methoxy-2-naphthylacetic acid prodrugs
US6436990B1 (en)	1999-10-27	2002-08-20	Nobex Corporation	6-methoxy-2-naphthylacetic acid prodrugs
IL150368A0 (en) *	1999-12-23	2002-12-01	Nitromed Inc	Nitrosated and nitrosylated cyclooxygenase-2-inhibitors, compositions and methods of use
SE0000773D0 (sv) *	2000-03-08	2000-03-08	Astrazeneca Ab	New formulation
SE0000774D0 (sv)	2000-03-08	2000-03-08	Astrazeneca Ab	New formulation
AU2001285311B2 (en) *	2000-08-29	2005-09-15	Biocon, Ltd	Immunoregulatory compounds, derivatives thereof and their use
IT1319201B1 (it) *	2000-10-12	2003-09-26	Nicox Sa	Farmaci per il diabete.
IT1319202B1 (it)	2000-10-12	2003-09-26	Nicox Sa	Farmaci per le malattie a base infiammatoria.
US6706724B2 (en)	2000-12-21	2004-03-16	Nitromed, Inc.	Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use
EP1219306A1 (en)	2000-12-29	2002-07-03	Nicox S.A.	Compositions comprising cyclodextrins and NO- releasing drugs
US7060675B2 (en)	2001-02-15	2006-06-13	Nobex Corporation	Methods of treating diabetes mellitus
US6867183B2 (en)	2001-02-15	2005-03-15	Nobex Corporation	Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
GB0111872D0 (en) *	2001-05-15	2001-07-04	Northwick Park Inst For Medica	Therapeutic agents and methods
US6696592B2 (en)	2001-05-22	2004-02-24	Nicox-S.A.	Methods of making 21-[4′-(nitrooxyalkyl)benzoate] corticosteroid derivatives and intermediates useful in the synthesis thereof
US6713452B2 (en)	2001-06-04	2004-03-30	Nobex Corporation	Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US6828297B2 (en)	2001-06-04	2004-12-07	Nobex Corporation	Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US6858580B2 (en)	2001-06-04	2005-02-22	Nobex Corporation	Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
ITMI20011240A1 (it) *	2001-06-13	2002-12-13	Nicox Sa	Farmaci per le vasculopatie
ITMI20011308A1 (it)	2001-06-21	2002-12-21	Nicox Sa	Farmaci per il dolore cronico
ITMI20011307A1 (it) *	2001-06-21	2002-12-21	Nicox Sa	Farmaci per l'epilessia
US8048924B2 (en) *	2001-08-29	2011-11-01	Biocon Limited	Methods and compositions employing 4-aminophenylacetic acid compounds
US7166571B2 (en)	2001-09-07	2007-01-23	Biocon Limited	Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
US6913903B2 (en)	2001-09-07	2005-07-05	Nobex Corporation	Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
SE0102993D0 (sv)	2001-09-07	2001-09-07	Astrazeneca Ab	New self emulsifying drug delivery system
US7312192B2 (en)	2001-09-07	2007-12-25	Biocon Limited	Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
US7196059B2 (en)	2001-09-07	2007-03-27	Biocon Limited	Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
US20080026984A1 (en) *	2002-02-04	2008-01-31	Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda	Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
AU2003208525B9 (en) *	2002-02-04	2009-08-27	Alfama-Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda	Amend the invention title to read Method for treating a mammal by administration of a compound having the ability to release CO, compounds having the ability to release CO and pharmaceutical compositions thereof
US7968605B2 (en) *	2002-02-04	2011-06-28	ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda.	Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
ITMI20020773A1 (it) *	2002-04-11	2003-10-13	Nicox Sa	Farmaci per il trattamento dell'artrite
DE60302454T2 (de)	2002-04-19	2006-08-17	Yissum Research Development Company Of The Hebrew University Of Jerusalem	Beta-agonisten-verbindungen mit stickoxid-donatoren-gruppen und reaktionsfähige sauerstoffspezies-fängergruppen und ihre verwendung bei der behandlung von atemwegsstörungen
CA2487414A1 (en) *	2002-06-11	2003-12-18	Nitromed, Inc.	Nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use
US7601688B2 (en)	2002-06-13	2009-10-13	Biocon Limited	Methods of reducing hypoglycemic episodes in the treatment of diabetes mellitus
ITMI20021399A1 (it) *	2002-06-25	2003-12-29	Nicox Sa	Inibitori della cicloossigenasi 2
ITMI20021391A1 (it)	2002-06-25	2003-12-29	Nicox Sa	Nitroderivati di inibitori della cicloossigenasi-2
AU2003279622A1 (en) *	2002-06-28	2004-01-19	Nitromed, Inc.	Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxigenase-2 selective inhibitors, compositions and methods of use
JP2005539089A (ja) *	2002-07-03	2005-12-22	ニトロメッドインコーポレーティッド	ニトロソ化非ステロイド性抗炎症化合物、組成物および使用方法
AU2003252515A1 (en)	2002-07-26	2004-02-16	Merck Frosst Canada And Co.	Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as cyclooxygenase-2 inhibitors
JP2005538110A (ja) *	2002-07-29	2005-12-15	ニトロメッドインコーポレーティッド	シクロオキシゲナーゼ−２選択的阻害剤、組成物、および使用方法
ITMI20021861A1 (it)	2002-08-29	2004-02-29	Nicox Sa	Procedimento di sintesi di nitrossialchilesteri di acidi carbossilici, intermedi impiegabili in detto procedimento e loro preparazione.
BR0314365A (pt) *	2002-09-20	2005-07-19	Nicox Sa	Processos para a fabricação de compostos doadores de no e para a produção da forma a do composto iva, compostos, usos do processo, dos compostos, e da forma a do composto iva, e, formulação farmacêutica
SE0203093D0 (en) *	2002-10-18	2002-10-18	Astrazeneca Uk Ltd	New use
WO2004037843A2 (en) *	2002-10-25	2004-05-06	Yissum Research Development Company Of The Hebrew University Of Jerusalem	Steroid compounds comprising superoxide dismutase mimic groups and nitric oxide donor groups, and their use in the preparation of medicaments
GB2395432B (en) *	2002-11-20	2005-09-14	Northwick Park Inst For Medica	Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs
ITMI20022658A1 (it)	2002-12-17	2004-06-18	Nicox Sa	Farmaci per il dolore cronico.
US8512727B2 (en) *	2003-03-03	2013-08-20	Alkermes Pharma Ireland Limited	Nanoparticulate meloxicam formulations
US20100297252A1 (en)	2003-03-03	2010-11-25	Elan Pharma International Ltd.	Nanoparticulate meloxicam formulations
SE0301880D0 (sv) *	2003-06-25	2003-06-25	Astrazeneca Uk Ltd	New drug delivery composition
WO2005030224A1 (en) *	2003-09-26	2005-04-07	Nicox S.A.	Nitrosylated analgesic and/or anti-inflammatory drugs having antiviral activity
AU2005206229A1 (en)	2004-01-27	2005-08-04	Merck Frosst Company	Nitric oxide releasing prodrugs of diaryl-2-(5H)-furanones as cyclooxygenase-2 inhibitors
JP2007520483A (ja)	2004-01-27	2007-07-26	メルクフロストカンパニー	シクロオキシゲナーゼ−２インヒビターとしてのジアリール−２−（５ｈ）−フラノンの一酸化窒素放出プロドラッグ
US7932366B2 (en) *	2004-07-07	2011-04-26	Biocon Limited	Synthesis of azo bonded immunoregulatory compounds
US7872095B2 (en)	2004-07-19	2011-01-18	Biocon Limited	Insulin-oligomer conjugates, formulations and uses thereof
WO2006041855A2 (en)	2004-10-04	2006-04-20	Nitromed, Inc.	Compositions and methods using apocynin compounds and nitric oxide donors
WO2007073226A1 (en) *	2005-12-20	2007-06-28	Alfama - Investigação E Desenvolvimento De Produtos Farmacêuticos Lda	Method for treating a mammal by administration of a compound having the ability to release co
GB0601394D0 (en)	2006-01-24	2006-03-01	Hemocorm Ltd	Therapeutic delivery of carbon monoxide
US8575222B2 (en) *	2006-02-03	2013-11-05	Nicox S.A.	Use of nitrooxyderivatives of drug for the treatment of muscular dystrophies
JP2007275193A (ja) *	2006-04-04	2007-10-25	Fujifilm Corp	光プローブおよび光断層画像化装置
CN101939023B (zh)	2007-10-16	2016-08-03	百康有限公司	可经口给药的固体药物组合物及其方法
US8044105B2 (en)	2008-02-04	2011-10-25	Dow Global Technologies Llc	Water-based ceramic foams showing improved gel strength
WO2010118968A1 (en)	2009-04-16	2010-10-21	Nicox S.A.	No-donor aspirin derivatives
US20100286272A1 (en) *	2009-05-08	2010-11-11	Perricone Nicholas V	Methods Of Use Of Nitroalkene Compositions In Dermatologic Applications
US20100286257A1 (en) *	2009-05-08	2010-11-11	Perricone Nicholas V	Methods Of Use Of Nitroalkane Compositions In Dermatologic Applications To Prevent or Treat Skin Aging
US20100286271A1 (en) *	2009-05-08	2010-11-11	Perricone Nicholas V	Nitro-alkyl Compound Compositions
WO2011133385A2 (en) *	2010-04-16	2011-10-27	The Research Foundation Of State University Of New York	Novel ether-based compounds and their use
PT2699242T (pt)	2011-04-19	2018-01-22	Alfama Inc	Moléculas de libertação de monóxido de carbono e utilizações das mesmas
JP6134710B2 (ja)	2011-07-21	2017-05-24	アルファーマインコーポレイテッドＡｌｆａｍａ，Ｉｎｃ．	一酸化ルテニウム放出分子およびその使用
US9844599B2 (en)	2013-01-21	2017-12-19	Apparao Satyam	Nitric oxide releasing produgs of therapeutic agents
US20140271923A1 (en)	2013-03-14	2014-09-18	Christopher Brian Reid	Compositions & formulations for preventing and treating chronic diseases that cluster in patients such as cardiovascular disease, diabetes, obesity, polycystic ovary syndrome, hyperlipidemia and hypertension, as well as for preventing and treating other diseases and conditions
WO2021195126A1 (en)	2020-03-24	2021-09-30	Burnet Michael W	Anti-infective and anti-viral compounds and compositions
WO2023129958A2 (en) *	2021-12-28	2023-07-06	ATAI Life Sciences AG	Nitric oxide releasing prodrugs of mda and mdma

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1243367B (it) *	1990-07-26	1994-06-10	Italfarmaco Spa	Derivati acidi benzoici sostituiti ad attivita' cardiovascolare
JPH04134077A (ja) *	1990-09-21	1992-05-07	Taiho Yakuhin Kogyo Kk	イソオキサゾール化合物
IT1256345B (it) *	1992-08-20	1995-12-01		Esteri nitrici di derivati dell'acido 2-(2,6-di-alo-fenilammino) fenilacetico e procedimento per la loro preparazione
IT1256450B (it) *	1992-11-26	1995-12-05	Soldato Piero Del	Esteri nitrici con attivita' farmacologica e procedimento per la loro preparazione

1995
- 1995-04-04 BR BR9507634A patent/BR9507634A/pt not_active IP Right Cessation
- 1995-04-04 HU HU9603107A patent/HU227280B1/hu not_active IP Right Cessation
- 1995-04-04 SI SI9530312T patent/SI0759899T1/xx not_active IP Right Cessation
- 1995-04-04 KR KR1019960706360A patent/KR100387359B1/ko not_active Expired - Fee Related
- 1995-04-04 DK DK95915185T patent/DK0759899T3/da active
- 1995-04-04 CA CA002190087A patent/CA2190087C/en not_active Expired - Fee Related
- 1995-04-04 AT AT95915185T patent/ATE184589T1/de not_active IP Right Cessation
- 1995-04-04 DE DE69512232T patent/DE69512232T2/de not_active Expired - Lifetime
- 1995-04-04 JP JP52861595A patent/JP4043046B2/ja not_active Expired - Fee Related
- 1995-04-04 AU AU22156/95A patent/AU702662B2/en not_active Ceased
- 1995-04-04 WO PCT/EP1995/001233 patent/WO1995030641A1/en not_active Ceased
- 1995-04-04 RU RU96123280A patent/RU2145595C1/ru not_active IP Right Cessation
- 1995-04-04 EP EP95915185A patent/EP0759899B1/en not_active Expired - Lifetime
- 1995-04-04 ES ES95915185T patent/ES2139199T3/es not_active Expired - Lifetime
- 1995-04-04 US US08/737,426 patent/US5861426A/en not_active Expired - Lifetime
- 1995-04-05 IL IL11325595A patent/IL113255A0/xx not_active IP Right Cessation
1999
- 1999-12-08 GR GR990403169T patent/GR3032078T3/el unknown

Also Published As

Publication number	Publication date
GR3032078T3 (en)	2000-03-31
KR100387359B1 (ko)	2003-08-27
DK0759899T3 (da)	1999-12-20
JP4043046B2 (ja)	2008-02-06
SI0759899T1 (en)	1999-12-31
AU2215695A (en)	1995-11-29
EP0759899B1 (en)	1999-09-15
HU9603107D0 (en)	1997-01-28
ATE184589T1 (de)	1999-10-15
HUT75961A (en)	1997-05-28
ES2139199T3 (es)	2000-02-01
DE69512232T2 (de)	2000-02-24
KR970702839A (ko)	1997-06-10
RU2145595C1 (ru)	2000-02-20
CA2190087A1 (en)	1995-11-16
CA2190087C (en)	2005-08-02
DE69512232D1 (de)	1999-10-21
IL113255A0 (en)	1995-07-31
WO1995030641A1 (en)	1995-11-16
US5861426A (en)	1999-01-19
AU702662B2 (en)	1999-02-25
JPH09512798A (ja)	1997-12-22
EP0759899A1 (en)	1997-03-05
HU227280B1 (en)	2011-01-28

Publication	Publication Date	Title
BR9507634A (pt)	1997-09-23	Compostos ou suas composições e uso dos mesmos
TR199700419A2 (xx)	1997-12-21	Yeni piridazinon t�revleri.
DE69310501D1 (de)	1997-06-12	Chinolylbenzofuran derivate als leukotrien-antagonisten
BR9611175A (pt)	1999-03-30	Compostos ou suas composições e uso dos mesmo
ATE231143T1 (de)	2003-02-15	Triarylimidazole
MY141444A (en)	2010-04-30	Carboxamidothiazole derivatives, preparation, pharmaceutical compositions containing them
DE69716461D1 (de)	2002-11-21	Antithrombotische organische nitrate
CA2176935A1 (fr)	1995-05-26	Arylpiperazines derivees d'indole comme ligands pour les recepteurs 5 ht1-like 5 ht1b et 5 ht1d
ATE181731T1 (de)	1999-07-15	Isothioharnstoff-derivate als no synthase hemmer
CA2057786A1 (en)	1992-06-22	Amino and nitro containing tricyclic compounds useful as inhibitors or ace
AU541811B2 (en)	1985-01-24	Quinazoline derivatives
DE69516186D1 (de)	2000-05-11	Verwendung von Beta-Aminopropionsäure-Derivaten als Fungizide
TW355705B (en)	1999-04-11	Substituted benzyloxycarbonylguanidines, process for their preparation, their medical use and pharmaceutical composition containing them
ATE213241T1 (de)	2002-02-15	Amidin- und isothioharnstoffderivate als inhibitoren der stickstoffoxid-synthase
TR199902955T2 (xx)	2000-06-21	Anjiogenez inhibit�r� tiadiazolil piridazin t�revleri.
EA200001107A1 (ru)	2001-04-23	ПРОИЗВОДНЫЕ ОКТАГИДРО-6,10-ДИОКСО-6H-ПИРИДАЗИНО [1,2-a] [1,2] ДИАЗЕПИН-1-КАРБОНОВОЙ КИСЛОТЫ, СПОСОБ ПОЛУЧЕНИЯ И ИХ ПРИМЕНЕНИЕ ДЛЯ ПОЛУЧЕНИЯ ТЕРАПЕВТИЧЕСКИ АКТИВНЫХ СОЕДИНЕНИЙ
TR200001122T2 (tr)	2000-08-21	Farmasötikler olarak bifenil türevleri.
TR199900984T2 (xx)	1999-07-21	Benzens�lfonamid t�revleri ve ad� ge�en t�revleri i�eren ila�lar.
EA199800289A1 (ru)	1998-08-27	Производные пептидов
TR200003570T2 (tr)	2001-04-20	Mumbaistatin, Üretim yöntemi ve farmasötik kullanımı
CA2245484A1 (en)	1999-02-27	Novel urea derivatives
GB1475241A (en)	1977-06-01	Benzodiazocine derivatives and pharmaceutical compositions containing them
DK0625972T3 (da)	1996-04-01	Fremgangsmåde til fremstilling af 2-amino-7-nitrobenzothiazoler
TH46362A3 (th)	2001-07-24	สารผสมดูแลส่วนบุคคลชนิดใสที่มีสารประกอบควอเทอนารีแอมโมเนียมและสารประกอบที่มีไนโตรเจนชนิดอื่น

Legal Events

Date	Code	Title	Description
2001-09-25	FB36	Technical and formal requirements: requirement - article 36 of industrial property law
2002-04-30	HJEG	Technical examination (opinion): technical examination (opinion) related to article 229 of industrial property law
2004-03-09	FB36	Technical and formal requirements: requirement - article 36 of industrial property law
2004-07-06	B06A	Patent application procedure suspended [chapter 6.1 patent gazette]
2005-10-04	B09A	Decision: intention to grant [chapter 9.1 patent gazette]
2005-12-06	B16A	Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]	Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 06/12/2005, OBSERVADAS AS CONDICOES LEGAIS.
2006-08-15	B25G	Requested change of headquarter approved	Owner name: NICOX S.A. (FR) Free format text: ANOTADAS AS ALTERACOES DE SEDE SOLICITADAS NA PETICAO NO 020050046572/RJ DE 06/06/2005.
2007-06-26	B25G	Requested change of headquarter approved	Owner name: NICOX S.A. (FR) Free format text: ANOTADAS AS ALTERACOES DE SEDE SOLICITADA NA PETICAO NO 020070016104/RJ DE 07/02/2007.
2013-10-08	B22O	Other matters related to patents and certificates of addition of invention: legal action concerning patent	Free format text: INPI-52400.061577/2013 ORIGEM: JUIZO DA 013A VARA FEDERAL DO RIO DE JANEIRO PROCESSO NO 0132353-78.2013.4.02.5101 ACAO DE NULIDADE DAS PATENTES SUBMETIDAS AO MAILBOX (ART. 229, PARAGRAFO UNICO DA LPI); ALTERNATIVAMENTE, A DECRETACAO DA NULIDADE PARCIAL PARA CORRECAO DO PRAZO DE VIGENCIA; SUBSIDIARIAMENTE, CASO SE ENTENDA NAO SER O CASO DE NULIDADE, A CORRECAO DO ATO ADMINISTRATIVO PARA ADEQUACAO DA VIGENCIA DAS PATENTES. AUTOR: INSTITUTO NACIONAL DA PROPRIEDADE INDUSTRIAL - INPI REU: KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO, LONDON BIOTECHNOLOGY LIMITED, MERCK SHARP AND DOHME, N.V. ORGANON, NICOX S.A.
2013-10-29	B24H	Lapse because of non-payment of annual fees (definitively: art 78 iv lpi)	Free format text: EXTINCAO DEFINITIVA - ART. 78 INCISO IV DA LPI
2019-10-22	B19A	Notification of judicial decision: notification of judicial decision	Free format text: INPI-52400.061577/2013-10 SECAO JUDICIARIA DO RIO DE JANEIRO 9A VARA FEDERAL DO RIO DE JANEIRO PROCESSO: NO0132353-78.2013.4.02.5101APELANTE: MERCK SHARP AND DOHME CORP E OUTROS APELADO: INSTITUTO NACIONAL DA PROPRIEDADE INDUSTRIAL ? INPI DECISAO: A CONTROVERSIA SOBRE O PRAZO DE VIGENCIA DAS PATENTES MAILBOX FOI DEVIDAMENTE APRECIADA POR ESTE TRIBUNAL NO AMBITO DAS TURMAS ESPECIALIZADAS, ASSIM COMO TAMBEM NO DA SECAO, ALEM DO E. STJ, TENDO SIDO CONSOLIDADO O ENTENDIMENTO NO SENTIDO DE QUE O PARAGRAFO UNICO DO ARTIGO 40 DA LEI NO9.279/96 NAO SE APLICA AS PATENTES ?MAILBOX?, DIANTE DA LIMITACAO ESTABELECIDA PELO ARTIGO 229, PARAGRAFO UNICO, DA MESMA LEI DEVENDO SER APLICADO O PRAZO DE VIGE
2020-11-24	B24F	Patent annual fee: publication cancelled	Free format text: ANULADA A PUBLICACAO CODIGO 24.8 NA RPI NO 2234 DE 29/10/2013 POR TER SIDO INDEVIDA.
2021-08-31	B21F	Lapse acc. art. 78, item iv - on non-payment of the annual fees in time	Free format text: REFERENTE A 17A, 18A, 19A E 20A RETRIBUICAO ANUAL